Currently holds a position at Clearside Biomedical Inc
Position | Company | Period |
---|---|---|
Chief Financial Officer | Clearside Biomedical Inc | Jan. 1, 2012 - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-01-19 | 2024-01-19 |
Clearside Biomedical Inc
(CLSD)
|
S Sale |
12,900
-3.2%
1.2816,512 USD |
12,900 -3.2% | 1.28 | 16,512 USD | |
2023-01-20 | 2023-01-19 |
Clearside Biomedical Inc
(CLSD)
|
PS Planned sale |
14,030
-3.7%
1.5021,045 USD |
14,030 -3.7% | 1.50 | 21,045 USD | |
2022-01-20 | 2022-01-19 |
Clearside Biomedical Inc
(CLSD)
|
PS Planned sale |
8,833
-2.5%
2.0918,461 USD |
8,833 -2.5% | 2.09 | 18,461 USD | |
2021-06-23 | 2021-06-21 |
Clearside Biomedical Inc
(CLSD)
|
PS Planned sale |
2,938
-0.9%
4.3712,839 USD |
2,938 -0.9% | 4.37 | 12,839 USD | |
2020-06-03 | 2020-06-01 |
Clearside Biomedical Inc
(CLSD)
|
PS Planned sale |
14,992
-6.4%
1.8828,185 USD |
14,992 -6.4% | 1.88 | 28,185 USD | |
2019-11-13 | 2019-11-12 |
Clearside Biomedical Inc
(CLSD)
|
B Purchase |
7,500
+3.8%
1.148,550 USD |
7,500 +3.8% | 1.14 | 8,550 USD | |
2019-03-18 | 2019-03-15 |
Clearside Biomedical Inc
(CLSD)
|
B Purchase |
10,000
+15.1%
1.3613,600 USD |
10,000 +15.1% | 1.36 | 13,600 USD | |
2018-03-26 | 2018-03-23 |
Clearside Biomedical Inc
(CLSD)
|
B Purchase |
500
+0.8%
11.795,895 USD |
500 +0.8% | 11.79 | 5,895 USD | |
2017-08-14 | 2017-08-14 |
Clearside Biomedical Inc
(CLSD)
|
B Purchase |
1,000
+1.6%
7.077,065 USD |
1,000 +1.6% | 7.07 | 7,065 USD | |
2016-06-07 | 2016-06-07 |
Clearside Biomedical Inc
(CLSD)
|
S Sale |
2
-0.0%
7.0014 USD |
2 -0.0% | 7.00 | 14 USD |